AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15289793
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rosuvastatin for 10 days
Trial: 11410117
Drug: Low-sodium (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium (50 mmol/day), low-nitrate (400 micromol/day) diet supplemented with NaCl tablets (200 mmol/day) for 7 days
Trial: 9240301
Drug: Heparin-coated extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated extracorporeal circuit (n = 15)
Trial: 8317868
Drug: Reperfusion solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reperfusion solution
Trial: 29054128
Drug: Combination varenicline/bupropion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination varenicline/bupropion treatment
Trial: 23782896
Drug: Roux-en-Y gastric
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roux-en-Y gastric bypass (RYGB) with standardized medical treatment if needed
Trial: 23782896
Drug: Standardized medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized medical treatment (control group)
Trial: 16766775
Drug: Combination high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination high FV, low-fat intervention
Trial: 15528909
Drug: High-dose sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sodium fluoride dentifrice (2,800 ppm F, high-NaF)
Trial: 3429174
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) glucagon
Trial: 15738750
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg modafinil
Trial: 17603048
Drug: Sibutramine 15
RxNorm normalized name: sibutramine 15 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 15 mg once daily with brief lifestyle modification
Trial: 17115902
Drug: HCV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV therapy
Trial: 12663719
Drug: Oxaliplatin 130
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 130 mg/m² day 1 plus capecitabine 2,000 mg/m²/d days 1 to 14 every 3 weeks (arm A)
Trial: 12663719
Drug: Oxaliplatin 85
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 85 mg/m² days 1 and 14 combined with capecitabine 3,500 mg/m² days 1 to 7 and 14 to 21 every 4 weeks (arm B)
Trial: 31909703
Drug: Typical physical
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical physical therapy (Control)
Trial: 31226660
Drug: Subliminal intragastric
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAGASTRIC LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subliminal intragastric infusion of 2.5 g lauric acid
Trial: 26859547
Drug: 0.4 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 μg/kg dexmedetomidine (small dose)
Trial: 26859547
Drug: 0.8 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 μg/kg dexmedetomidine (medium dose)
Trial: 24078278
Drug: DA-3031 (1.8,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA-3031 (1.8, 3.6, 6, or 18 mg)
Trial: 24078278
Drug: DA-3031 (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA-3031 (3.6 to 6 mg)
Trial: 24078278
Drug: Filgrastim (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgrastim (100 μg/m² daily for 5 days)
Trial: 17012110
Drug: Correlation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correlation of serum bFGF levels with FSH administration
Trial: 10981170
Drug: Candesartan cilexitil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexitil (angiotensin receptor blocker)
Trial: 27983687
Drug: Whole barley
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole barley flour (48 g)
Trial: 22936658
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (CT) with lenalidomide and rhu-EPO (40,000 U/wk)
Trial: 8963958
Drug: Systemically ineffective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemically ineffective dose of AII
Trial: 8963958
Drug: Systemically effective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemically effective dose of AII
Trial: 27503091
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR (400 mg/day)
Trial: 23647356
Drug: 2% Chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% Chlorhexidine digluconate gel (CHX)
Trial: 23647356
Drug: Chemomechanical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemomechanical preparation with 3% sodium hypochlorite (NaOCl)
Trial: 22882916
Drug: Amoxicillin‐clavulanate +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin‐clavulanate + ciprofloxacin (250 mg; one dose before and two doses after biopsy)
Trial: 16024926
Drug: High-dose citric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose citric acid-based UBT at 14 days after triple therapy
Trial: 16024926
Drug: High-dose citric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose citric acid-based UBT at 7 days after triple therapy
Trial: 16024926
Drug: Gold standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gold standard UBT at 6 weeks after therapy
Trial: 23146246
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg
Trial: 12601506
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg plus Cyproheptadine 4 mg
Trial: 12601506
Drug: Paroxetine 40
RxNorm normalized name: PARoxetine 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 40 mg plus Cyproheptadine 4 mg
Trial: 10365576
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy (interferon-alpha 2b) for 6 months
Trial: 8660081
Drug: Colestipol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol (10 g/day)
Trial: 1826048
Drug: ZOLADEX (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZOLADEX (3.6 mg every 28 days by subcutaneous injection)
Trial: 1826048
Drug: DES (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DES (3 mg daily by oral administration)
Trial: 16029995
Drug: Calcium-channel blockers
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-channel blockers (CCB)
Trial: 16029995
Drug: Irbesartan, ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan, ACE inhibitors, CCB
Trial: 8559949
Drug: Continuation light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation light treatment until late winter (n = 8)
Trial: 2706319
Drug: Research Suspension
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Research Suspension (RS)
Trial: 2706319
Drug: Reference Oral
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Reference Oral Solution (SOL)
Trial: 2706319
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations (MS, RS, SOL)
Trial: 29668611
Drug: Sham intradermal
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham intradermal needle
Trial: 29668611
Drug: Intradermal needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal needle
Trial: 18454914
Drug: 3.5% solution
RxNorm normalized name: Aminosyn 3.5% Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5% solution of betadine irrigation before final closing of the wound (Group 1)
Trial: 8737690
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 400 mg orally TID for 3 days preoperatively and 300 mg infusion after anesthetic induction
Trial: 24509273
Drug: Evolocumab (AMG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (AMG 145) 140 mg every 2 weeks
Trial: 24509273
Drug: Evolocumab (AMG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (AMG 145) 420 mg every 4 weeks
Trial: 15616296
Drug: Telavancin 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telavancin 7.5 mg/kg/day
Trial: 15616296
Drug: Telavancin 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telavancin 12.5 mg/kg/day
Trial: 15616296
Drug: Telavancin 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telavancin 15 mg/kg/day
Trial: 15616296
Drug: Telavancin (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telavancin (multiple doses)
Trial: 12062586
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of M. officinalis (Pharmaton)
Trial: 12062586
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of M. officinalis (Pharmaton)
Trial: 12062586
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of M. officinalis (Pharmaton)
Trial: 421548
Drug: High-nicotine cigarette
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-nicotine cigarette (2.6 mg nicotine, 4.5 vol percent CO)
Trial: 421548
Drug: Low-nicotine cigarette
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-nicotine cigarette (0.1 mg nicotine, 1.1 vol percent CO)
Trial: 421548
Drug: Cigar (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigar (not inhaled)
Trial: 421548
Drug: High-nicotine cigarette
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-nicotine cigarette after beta blocker
Trial: 421548
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of CO
Trial: 22070180
Drug: Medication-free subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-free subjects with autism (n=77)
Trial: 7565419
Drug: I.V. propofol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I.V. propofol 2.5 mg/kg (G1, G3, G5)
Trial: 7565419
Drug: Thiopental 5
RxNorm normalized name: thiopental 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 5 mg/kg (G2, G4, G6)
Trial: 465920
Drug: Contrast medium
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast medium containing 53 mg iodine/kg body weight
Trial: 465920
Drug: Contrast medium
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast medium containing 75 mg iodine/kg body weight
Trial: 465920
Drug: Contrast medium
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast medium containing 106 mg iodine/kg body weight
Trial: 465920
Drug: Infusion technique
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion technique over 3-8 hours
Trial: 465920
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage regimen (106 mg and 150 mg iodine/kg)
Trial: 25559090
Drug: Group-based memory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based memory rehabilitation programme (10 weekly sessions)
Trial: 17512355
Drug: 80 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/day of statins
Trial: 19778662
Drug: Statin therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapies
Trial: 9676471
Drug: Oral tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tenoxicam 40 mg
Trial: 7833497
Drug: Insulin at
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin at 5 microU/mL
Trial: 7833497
Drug: Gliclazide treatment
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide treatment
Trial: 21761263
Drug: Postexperimental inquiries
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postexperimental inquiries (PEI) administered as a face-to-face interview
Trial: 15965424
Drug: 12-week alefacept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-week alefacept treatment
Trial: 8067226
Drug: Heparin-coated equipment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated equipment (CBAS) with reduced i.v. heparin (1.5 mg.kg‐1)
Trial: 8067226
Drug: Noncoated equipment
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Noncoated equipment with full heparinization (3 mg.kg‐1)
Trial: 27505301
Drug: Concomitant Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant Therapy (CT) 14-day
Trial: 25129681
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (2 mg/kg first dose, followed by 2 mg/kg/d in 2 divided doses for 3 days)
Trial: 11709454
Drug: Exercise treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise treatment from a physiotherapist in primary care for 12 weeks
Trial: 7943088
Drug: Double-dose dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Double-dose dexamethasone (10 mg intravenously every 12 hours until delivery)
Trial: 31710864
Drug: Lenvatinib 24
RxNorm normalized name: lenvatinib 24 MG Daily Dose 30 Day Supply Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenvatinib 24 mg/day
Trial: 1450096
Drug: Disopyramide (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disopyramide (2 mg/kg body weight)
Trial: 26865162
Drug: Acceptance Commitment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance Commitment Therapy (up to eight sessions, each 1 hour)
Trial: 26865162
Drug: Acceptance Commitment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance Commitment Therapy
Trial: 15996416
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied three times per week for 16 weeks
Trial: 11923046
Drug: L-arginine (700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (700 mg) administered four times daily during TD-GTN therapy
Trial: 9811376
Drug: Capsaicin in
RxNorm normalized name: capsaicin in castor oil 0.035 % TOPICAL LIQUID (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin in candy formulation
Trial: 7666103
Drug: Oral clodronate
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clodronate 1,600 mg/d (n = 27)
Trial: 2564949
Drug: recombinant pro-urokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant pro-urokinase (rscu-PA) 80 mg (20 mg bolus followed by 60 mg infusion for 60 min)
Trial: 401690
Drug: Oral isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral isosorbide dinitrate (ISDN), mean dose 29 mg
Trial: 10353581
Drug: Sublingual placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual placebo
Trial: 20151522
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of rocuronium
Trial: 20151522
Drug: Cumulative fractional
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative fractional doses of rocuronium
Trial: 20151522
Drug: Bolus dose
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus dose of 400 microg-Kg(‐1) of rocuronium
Trial: 10863856
Drug: Ribavirin 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin 1,200 mg/day for 24 weeks
Trial: 8922661
Drug: Sequential HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential HRT
Trial: 1332094
Drug: MCPP (0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCPP (0.35 mg/kg)
Trial: 18082737
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate tablets
Trial: 11406744
Drug: Serious adverse
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serious adverse drug reactions observed by general practitioners
Trial: 9003851
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) at a dosage of 15 mg/kg per day, increased to 30 mg/kg per day if necessary
Trial: 28468518
Drug: oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral morphine
Trial: 26940689
Drug: transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: transdermal fentanyl
Trial: 24712653
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g of a standardized ginger extract per day (300 mg per capsule, administered q.i.d for five days during the first three cycles of chemotherapy)
Trial: 24712653
Drug: Standard anti-emetic
RxNorm normalized name: INVESTIGATIONAL ANTI-NAUSEA AND ANTI-EMETIC DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard anti-emetic therapy (placebo)
Trial: 22574741
Drug: 300 ml
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 ml apple juice
Trial: 22574741
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol with 300 ml water
Trial: 18794187
Drug: Internet‐based cognitive‐behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet‐based cognitive‐behavioral therapy (NET)
Trial: 9313245
Drug: Somnium (lorazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somnium (lorazepam 1 mg plus diphenhydramine 25 mg)
Trial: 28364943
Drug: Lorazepam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (1 mg)
Trial: 8365305
Drug: ATIII (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATIII (90 to 120 IU/kg in loading dose, then 90 to 120 IU/kg/d during 4 days)
Trial: 24089587
Drug: Infliximab (IFX)
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab (IFX) treatment
Trial: 24669774
Drug: Dose to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose to the ipsilateral masseter
Trial: 21734980
Drug: Potassium oxalate‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium oxalate‐based desensitizing agent (BisBlock) with Adper Single Bond 2 adhesive
Trial: 21734980
Drug: Adper Single
RxNorm normalized name: Asper-Flex
DrugBank: Trolamine salicylate (DB11079)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adper Single Bond 2 adhesive without desensitizing agent
Trial: 21734980
Drug: One‐Step adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One‐Step adhesive with potassium oxalate‐based desensitizing agent (BisBlock)
Trial: 21734980
Drug: One‐Step adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One‐Step adhesive without desensitizing agent
Trial: 22011421
Drug: Direct-to-smoker (DTS)
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-to-smoker (DTS) outreach offering free tobacco treatment including up to 8 weeks of nicotine patches (NRT)
Trial: 22011421
Drug: Direct-to-smoker (DTS)
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-to-smoker (DTS) outreach offering free tobacco treatment
Trial: 789436
Drug: Flunisolide (0.025%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunisolide (0.025% solution, two sprays in each nostril twice a day for 4 weeks)
Trial: 11564390
Drug: Omapatrilat 25
RxNorm normalized name: OMAPATRILAT
DrugBank: Omapatrilat (DB00886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat 25 mg and 50 mg
Trial: 30811620
Drug: Microwave treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microwave treatment at maximum energy level (5.8 GHz/axilla)
Trial: 26479510
Drug: Moderate neuromuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate neuromuscular blockade (single bolus of rocuronium 0.3 mg kg with spontaneous recovery) and standard-pressure pneumoperitoneum (12 mmHg)
Trial: 10337859
Drug: Mesterolone 100
RxNorm normalized name: mesterolone
DrugBank: Mesterolone (DB13587)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesterolone 100 mg orally daily (MES)